$MYSZ
My Size, Inc.

2024 Q4 Form 10-Q Financial Statement

#000149315224045931 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.839M
YoY Change -14.7%
Cost Of Revenue $1.048M
YoY Change 34.36%
Gross Profit $791.0K
YoY Change -42.51%
Gross Profit Margin 43.01%
Selling, General & Admin $1.377M
YoY Change -38.5%
% of Gross Profit 174.08%
Research & Development $89.00K
YoY Change -63.22%
% of Gross Profit 11.25%
Depreciation & Amortization $168.0K
YoY Change 95.35%
% of Gross Profit 21.24%
Operating Expenses $2.097M
YoY Change -15.48%
Operating Profit -$1.306M
YoY Change 18.19%
Interest Expense $6.000K
YoY Change -53.85%
% of Operating Profit
Other Income/Expense, Net $6.000K
YoY Change -72.73%
Pretax Income -$1.300M
YoY Change 19.05%
Income Tax
% Of Pretax Income
Net Earnings -$1.300M
YoY Change 14.84%
Net Earnings / Revenue -70.69%
Basic Earnings Per Share -$1.25
Diluted Earnings Per Share -$1.25
COMMON SHARES
Basic Shares Outstanding 1.260M shares 1.067M shares
Diluted Shares Outstanding 1.040M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.371M
YoY Change -35.83%
Cash & Equivalents $2.371M
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change -100.0%
Inventory $2.238M
Prepaid Expenses
Receivables $327.0K
Other Receivables $1.013M
Total Short-Term Assets $5.949M
YoY Change -26.28%
LONG-TERM ASSETS
Property, Plant & Equipment $66.00K
YoY Change -41.07%
Goodwill $131.0K
YoY Change -90.65%
Intangibles $845.0K
YoY Change -26.46%
Long-Term Investments $7.000K
YoY Change -90.41%
Other Assets $7.000K
YoY Change -73.08%
Total Long-Term Assets $1.083M
YoY Change -65.43%
TOTAL ASSETS
Total Short-Term Assets $5.949M
Total Long-Term Assets $1.083M
Total Assets $7.032M
YoY Change -37.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.329M
YoY Change -49.22%
Accrued Expenses $16.00K
YoY Change -88.32%
Deferred Revenue
YoY Change
Short-Term Debt $123.0K
YoY Change -46.52%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.385M
YoY Change -47.85%
LONG-TERM LIABILITIES
Long-Term Debt $177.0K
YoY Change -33.96%
Other Long-Term Liabilities $12.00K
YoY Change -92.31%
Total Long-Term Liabilities $189.0K
YoY Change -72.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.385M
Total Long-Term Liabilities $189.0K
Total Liabilities $2.574M
YoY Change -51.17%
SHAREHOLDERS EQUITY
Retained Earnings -$63.16M
YoY Change 7.82%
Common Stock $1.000K
YoY Change -66.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.458M
YoY Change
Total Liabilities & Shareholders Equity $7.032M
YoY Change -37.23%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.300M
YoY Change 14.84%
Depreciation, Depletion And Amortization $168.0K
YoY Change 95.35%
Cash From Operating Activities -$447.0K
YoY Change -64.8%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -335.0K
YoY Change -109.22%
NET CHANGE
Cash From Operating Activities -447.0K
Cash From Investing Activities 0.000
Cash From Financing Activities -335.0K
Net Change In Cash -782.0K
YoY Change -133.08%
FREE CASH FLOW
Cash From Operating Activities -$447.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.25
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.52
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1040446 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1040446 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
319922 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
319922 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1105000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-78000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Registrant Name
EntityRegistrantName
MY SIZE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
51-0394637
dei Entity Address Address Line1
EntityAddressAddressLine1
HaNegev 4
dei Entity Address Address Line2
EntityAddressAddressLine2
POB 1026
dei Entity Address City Or Town
EntityAddressCityOrTown
Airport City
dei Entity Address Country
EntityAddressCountry
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
7010000
dei City Area Code
CityAreaCode
972
dei Local Phone Number
LocalPhoneNumber
3-600-9030
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
MYSZ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2371000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2238000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
327000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1013000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
5949000 usd
CY2024Q3 us-gaap Deposit Assets
DepositAssets
7000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
845000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
131000 usd
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
7000 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1083000 usd
CY2024Q3 us-gaap Assets
Assets
7032000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16000 usd
CY2024Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
123000 usd
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1329000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
68000 usd
CY2024Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
849000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2385000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
177000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
2574000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
242000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2598000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
737000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2572000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001211805
CY2024Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
dei Document Type
DocumentType
10-Q
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2187000 usd
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
77000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2879000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
615000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
847000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6627000 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
7000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
351000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
758000 usd
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
6000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2364000 usd
CY2023Q4 us-gaap Assets
Assets
8991000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
158000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
158000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2154000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
605000 usd
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
803000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3878000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
249000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
129000 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
189000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
378000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4256000 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
usd
CY2024Q3 MYSZ Short Term Deposit
ShortTermDeposit
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
CY2024Q3 MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
MYSZ Stock Issued During Period Value Effect Of Reverse Stock Splits
StockIssuedDuringPeriodValueEffectOfReverseStockSplits
usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
MYSZ Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
CY2024Q3 MYSZ Stock Issued During Period Value Exercise Of Shares In Abeyance
StockIssuedDuringPeriodValueExerciseOfSharesInAbeyance
usd
CY2023Q3 MYSZ Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
MYSZ Increase Decrease In Investment In Joint Venture
IncreaseDecreaseInInvestmentInJointVenture
usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
MYSZ Change In Operating Lease Rightofuse Asset And Liability
ChangeInOperatingLeaseRightofuseAssetAndLiability
usd
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37370
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1260131 shares
CY2023Q4 MYSZ Short Term Deposit
ShortTermDeposit
22000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1097000 usd
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
24000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1169131 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
452724 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
68514000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
65386000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-896000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-771000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63161000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59881000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
4458000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4735000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7032000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8991000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6802000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4166000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1839000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2156000 usd
us-gaap Cost Of Revenue
CostOfRevenue
3831000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2698000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1048000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
780000 usd
us-gaap Gross Profit
GrossProfit
2971000 usd
us-gaap Gross Profit
GrossProfit
1468000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
791000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1376000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
352000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
811000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2670000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
952000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3210000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
640000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1287000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
631000 usd
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
631000 usd
us-gaap Operating Expenses
OperatingExpenses
6225000 usd
us-gaap Operating Expenses
OperatingExpenses
6619000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2097000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2481000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3254000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5151000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1306000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22000 usd
MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
48000 usd
CY2023Q3 MYSZ Equity Loss Of Equity Method Investees
EquityLossOfEquityMethodInvestees
9000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3280000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5277000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1300000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1092000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-200000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3280000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5077000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1300000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1132000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-125000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-75000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-26000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-36000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3405000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5152000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1326000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1168000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.21
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-17.52
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-17.52
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.25
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
779319 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
779319 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
289373 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
289373 shares
us-gaap Inventory Write Down
InventoryWriteDown
643000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split effected in April 2024
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4735000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
306000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
442000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2819000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3405000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
4458000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split effected in April 2024
CY2023Q3 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
104375000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4536000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
290000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
959000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6258000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5152000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5932000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split effected in April 2024
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5695000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
89000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1326000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
4458000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
3433000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
68000 usd
CY2023Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
518000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3599000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1168000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
5932000 usd
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:8 reverse stock split effected in April 2024
us-gaap Net Income Loss
NetIncomeLoss
-3280000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5077000 usd
us-gaap Depreciation
Depreciation
33000 usd
us-gaap Depreciation
Depreciation
27000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-28000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
142000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
130000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
227000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
226000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-525000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
36000 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
43000 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
16000 usd
us-gaap Interest Paid
InterestPaid
38000 usd
us-gaap Interest Paid
InterestPaid
16000 usd
MYSZ Revaluation Of Investment In Marketable Securities
RevaluationOfInvestmentInMarketableSecurities
1000 usd
MYSZ Revaluation Of Investment In Marketable Securities
RevaluationOfInvestmentInMarketableSecurities
-21000 usd
MYSZ Increase Decrease In Investment In Joint Venture
IncreaseDecreaseInInvestmentInJointVenture
52000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
306000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
290000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-633000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1530000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
631000 usd
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-328000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-285000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1165000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-103000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-101000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
165000 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
351000 usd
MYSZ Increase Decrease In Trade Payable
IncreaseDecreaseInTradePayable
-774000 usd
MYSZ Increase Decrease In Trade Payable
IncreaseDecreaseInTradePayable
271000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
35000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
259000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2523000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4910000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
38000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
22000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2819000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6257000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
500000 usd
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
350000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
693000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
377000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2626000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6230000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-56000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
84000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1404000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2264000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2363000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2371000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3767000 usd
MYSZ Change In Operating Lease Rightofuse Asset And Liability
ChangeInOperatingLeaseRightofuseAssetAndLiability
181000 usd
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
184000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
77000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63161000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
631000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
1000 usd
CY2024Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
21000 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
3000 usd
CY2023Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
7000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
309000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
290000 usd
CY2024Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
89000 usd
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
68000 usd
CY2024Q1 us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
314000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Description
ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
(i) 5,000 shares of restricted common stock of the Company, (ii) a warrant to purchase 12,500 shares of common stock at an exercise price of $4.00 per share and exercisable for a term of 36 months from the date of issuance, and (iii) a warrant to purchase 12,500 shares of common stock at an exercise price of $6.00 per share and exercisable for a term of 36 months from the date of issuance
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
631000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
131000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1401000 usd
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q4 us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
The Notification Letter provided that the Company had 180 calendar days, or until May 1, 2024, to regain compliance with the Rule. To regain compliance, the bid price of the Company’s common stock must have had a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days. On May 7, 2024, the Company received a letter from Nasdaq that, for the 10 consecutive business days from April 23, 2024 to May 6, 2024, the closing bid price of the Company’s common stock had been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and Nasdaq considers the prior bid price deficiency matter now closed
CY2024Q3 us-gaap Shares Issued
SharesIssued
452989 shares
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-045931-index-headers.html Edgar Link pending
0001493152-24-045931-index.html Edgar Link pending
0001493152-24-045931.txt Edgar Link pending
0001493152-24-045931-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
mysz-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
mysz-20240930_cal.xml Edgar Link unprocessable
mysz-20240930_def.xml Edgar Link unprocessable
mysz-20240930_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
mysz-20240930_pre.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable